Aurora kinase A messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinoma
- PMID: 16951231
- DOI: 10.1158/1078-0432.CCR-05-1650
Aurora kinase A messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinoma
Abstract
Purpose: Aurora kinase A (AURKA/STK15/BTAK) encodes a serine/threonine kinase associated with chromosomal distribution and its up-regulation induces chromosomal instability, thereby leading to aneuploidy and cell transformation in several types of cancer. In this study, we investigated the role of AURKA in head and neck squamous cell carcinoma (HNSCC).
Experimental design: The mRNA expression levels of AURKA were compared in tumor tissues of 66 HNSCC patients with those in corresponding normal squamous epithelium by real-time quantitative reverse transcriptase-PCR. In addition, the association between AURKA mRNA and protein expression, centrosome abnormalities, and aneuploidy was studied in a subset of cases (n=34). All molecular variables were correlated to histomorphologic findings and clinical follow-up data of the patients.
Results: AURKA mRNA up-regulation was significantly associated with tumor stage and the occurrence of regional lymph node, as well as distant metastasis (P<0.0001 for all). Similarly, a correlation was found for protein expression and the occurrence of regional lymph node (P=0.0183) and distant metastasis (P=0.03). The mRNA was positively associated with protein expression (P=0.003) and centrosome abnormalities (P=0.03). Cox regression analysis revealed that AURKA mRNA up-regulation correlated with disease-free survival of the patients (P=0.03) as well as shorter overall survival (P<0.001).
Conclusions: We conclude that the up-regulation of AURKA mRNA may play a critical role in the tumor progression of HNSCC and provides useful information as a prognostic factor for HNSCC patients.
Comment in
-
Aurora sheds light on head and neck squamous cell carcinoma.Clin Cancer Res. 2006 Sep 1;12(17):5003-4. doi: 10.1158/1078-0432.CCR-06-1329. Clin Cancer Res. 2006. PMID: 16951211 Review. No abstract available.
-
Prognostic biomarkers in head and neck cancer.Clin Cancer Res. 2006 Sep 1;12(17):5005-6. doi: 10.1158/1078-0432.CCR-06-1356. Clin Cancer Res. 2006. PMID: 16951212 Review. No abstract available.
Similar articles
-
Prognostic biomarkers in head and neck cancer.Clin Cancer Res. 2006 Sep 1;12(17):5005-6. doi: 10.1158/1078-0432.CCR-06-1356. Clin Cancer Res. 2006. PMID: 16951212 Review. No abstract available.
-
Aurora sheds light on head and neck squamous cell carcinoma.Clin Cancer Res. 2006 Sep 1;12(17):5003-4. doi: 10.1158/1078-0432.CCR-06-1329. Clin Cancer Res. 2006. PMID: 16951211 Review. No abstract available.
-
The clinical significance of Aurora-A/STK15/BTAK expression in human esophageal squamous cell carcinoma.Clin Cancer Res. 2005 Mar 1;11(5):1827-34. doi: 10.1158/1078-0432.CCR-04-1627. Clin Cancer Res. 2005. PMID: 15756006
-
Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients.Clin Cancer Res. 2004 Dec 1;10(23):7827-33. doi: 10.1158/1078-0432.CCR-04-1090. Clin Cancer Res. 2004. PMID: 15585614
-
A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.Cancer Res. 2001 May 15;61(10):4122-9. Cancer Res. 2001. PMID: 11358835
Cited by
-
Regulation of Pre-mRNA Splicing: Indispensable Role of Post-Translational Modifications of Splicing Factors.Life (Basel). 2023 Feb 21;13(3):604. doi: 10.3390/life13030604. Life (Basel). 2023. PMID: 36983760 Free PMC article. Review.
-
Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario.Pharmaceutics. 2023 Feb 16;15(2):664. doi: 10.3390/pharmaceutics15020664. Pharmaceutics. 2023. PMID: 36839989 Free PMC article. Review.
-
Aurora Kinases as Therapeutic Targets in Head and Neck Cancer.Cancer J. 2022 Sep-Oct 01;28(5):387-400. doi: 10.1097/PPO.0000000000000614. Cancer J. 2022. PMID: 36165728 Free PMC article.
-
FBXL7 Body Hypomethylation Is Frequent in Tumors from the Digestive and Respiratory Tracts and Is Associated with Risk-Factor Exposure.Int J Mol Sci. 2022 Jul 15;23(14):7801. doi: 10.3390/ijms23147801. Int J Mol Sci. 2022. PMID: 35887149 Free PMC article.
-
Identification of Prognostic Markers for Head and NeckSquamous Cell Carcinoma Based on Glycolysis-Related Genes.Evid Based Complement Alternat Med. 2022 Jul 7;2022:2762595. doi: 10.1155/2022/2762595. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35845594 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
